Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Diverse compounds from pleuromutilin lead to a thioredoxin inhibitor and inducer of ferroptosis.

Llabani E, Hicklin RW, Lee HY, Motika SE, Crawford LA, Weerapana E, Hergenrother PJ.

Nat Chem. 2019 Jun;11(6):521-532. doi: 10.1038/s41557-019-0261-6. Epub 2019 May 13.

PMID:
31086302
2.

Predictors of Discharge Against Medical Advice in a Tertiary Paediatric Hospital.

Sealy L, Zwi K, McDonald G, Saavedra A, Crawford L, Gunasekera H.

Int J Environ Res Public Health. 2019 Apr 12;16(8). pii: E1326. doi: 10.3390/ijerph16081326.

3.

TRAF6 Silencing Attenuates Multiple Myeloma Cell Adhesion to Bone Marrow Stromal Cells.

Morgan JJ, McAvera RM, Crawford LJ.

Int J Mol Sci. 2019 Feb 6;20(3). pii: E702. doi: 10.3390/ijms20030702.

4.

Identification of a S. aureus virulence factor by activity-based protein profiling (ABPP).

Lentz CS, Sheldon JR, Crawford LA, Cooper R, Garland M, Amieva MR, Weerapana E, Skaar EP, Bogyo M.

Nat Chem Biol. 2018 Jun;14(6):609-617. doi: 10.1038/s41589-018-0060-1. Epub 2018 May 16.

5.

TRIM proteins in blood cancers.

Crawford LJ, Johnston CK, Irvine AE.

J Cell Commun Signal. 2018 Mar;12(1):21-29. doi: 10.1007/s12079-017-0423-5. Epub 2017 Nov 6. Review.

6.

KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients.

Quinti L, Dayalan Naidu S, Träger U, Chen X, Kegel-Gleason K, Llères D, Connolly C, Chopra V, Low C, Moniot S, Sapp E, Tousley AR, Vodicka P, Van Kanegan MJ, Kaltenbach LS, Crawford LA, Fuszard M, Higgins M, Miller JRC, Farmer RE, Potluri V, Samajdar S, Meisel L, Zhang N, Snyder A, Stein R, Hersch SM, Ellerby LM, Weerapana E, Schwarzschild MA, Steegborn C, Leavitt BR, Degterev A, Tabrizi SJ, Lo DC, DiFiglia M, Thompson LM, Dinkova-Kostova AT, Kazantsev AG.

Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4676-E4685. doi: 10.1073/pnas.1614943114. Epub 2017 May 22.

7.

An orthogonalized platform for genetic code expansion in both bacteria and eukaryotes.

Italia JS, Addy PS, Wrobel CJ, Crawford LA, Lajoie MJ, Zheng Y, Chatterjee A.

Nat Chem Biol. 2017 Apr;13(4):446-450. doi: 10.1038/nchembio.2312. Epub 2017 Feb 13.

PMID:
28192410
8.

Separation and Enrichment of Hematopoietic Stem Cells for CCN Studies.

Crawford LJ, Irvine AE.

Methods Mol Biol. 2017;1489:261-271.

PMID:
27734383
9.

Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myeloma.

Crawford LJ, Anderson G, Johnston CK, Irvine AE.

Oncotarget. 2016 Oct 25;7(43):70481-70493. doi: 10.18632/oncotarget.12026.

10.

The role of the CCN family of proteins in blood cancers.

Crawford LJ, Irvine AE.

J Cell Commun Signal. 2016 Sep;10(3):197-205. Epub 2016 Aug 3.

11.

GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity.

Louie SM, Grossman EA, Crawford LA, Ding L, Camarda R, Huffman TR, Miyamoto DK, Goga A, Weerapana E, Nomura DK.

Cell Chem Biol. 2016 May 19;23(5):567-578. doi: 10.1016/j.chembiol.2016.03.017. Epub 2016 May 12.

12.

Dosimetric Consequences of 3D Versus 4D PET/CT for Target Delineation of Lung Stereotactic Radiotherapy.

Siva S, Chesson B, Callahan JW, Hardcastle N, Crawford L, Antippa P, Wright G, MacManus MP, Hicks RJ, Kron T, Ball DL.

J Thorac Oncol. 2015 Jul;10(7):1112-5. doi: 10.1097/JTO.0000000000000555.

13.

The matricellular protein CCN3 regulates NOTCH1 signalling in chronic myeloid leukaemia.

Suresh S, McCallum L, Crawford LJ, Lu WH, Sharpe DJ, Irvine AE.

J Pathol. 2013 Nov;231(3):378-87.

14.

Targeting the ubiquitin proteasome system in haematological malignancies.

Crawford LJ, Irvine AE.

Blood Rev. 2013 Nov;27(6):297-304. doi: 10.1016/j.blre.2013.10.002. Epub 2013 Oct 19. Review.

PMID:
24183816
15.

Proteasome inhibitors in cancer therapy.

Crawford LJ, Walker B, Irvine AE.

J Cell Commun Signal. 2011 Jun;5(2):101-10. doi: 10.1007/s12079-011-0121-7. Epub 2011 Jan 31.

16.

Adiponectin is produced by lymphocytes and is a negative regulator of granulopoiesis.

Crawford LJ, Peake R, Price S, Morris TC, Irvine AE.

J Leukoc Biol. 2010 Oct;88(4):807-11. doi: 10.1189/jlb.1109723. Epub 2010 Jul 19.

PMID:
20643815
17.

Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD/SCID repopulating cells.

Heaney NB, Pellicano F, Zhang B, Crawford L, Chu S, Kazmi SM, Allan EK, Jorgensen HG, Irvine AE, Bhatia R, Holyoake TL.

Blood. 2010 Mar 18;115(11):2241-50. doi: 10.1182/blood-2008-06-164582. Epub 2010 Jan 12.

18.

Proteasome proteolytic profile is linked to Bcr-Abl expression.

Crawford LJ, Windrum P, Magill L, Melo JV, McCallum L, McMullin MF, Ovaa H, Walker B, Irvine AE.

Exp Hematol. 2009 Mar;37(3):357-66. doi: 10.1016/j.exphem.2008.11.004. Epub 2009 Jan 20.

PMID:
19157685
19.

The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood.

Kipps A, Alexander M, Colan SD, Gauvreau K, Smoot L, Crawford L, Darras BT, Blume ED.

Pediatr Cardiol. 2009 Apr;30(3):306-10. doi: 10.1007/s00246-008-9305-1. Epub 2008 Aug 21.

PMID:
18716706
20.

Proteasome inhibitors: a therapeutic strategy for haematological malignancy.

Crawford LJ, Walker B, Irvine AE.

Front Biosci. 2008 May 1;13:4285-96. Review.

PMID:
18508511

Supplemental Content

Loading ...
Support Center